Beijing Tongrentang Co Ltd

SHG:600085 China Drug Manufacturers - Specialty & Generic
Market Cap
$5.60 Billion
CN¥41.08 Billion CNY
Market Cap Rank
#4224 Global
#419 in China
Share Price
CN¥29.95
Change (1 day)
-0.40%
52-Week Range
CN¥29.71 - CN¥38.14
All Time High
CN¥62.33
Categories
Companies in China Drug Manufacturers - Specialty & Generic
About

Beijing Tongrentang Co., Ltd engages in the research, production, distribution, and sale of Chinese patent medicines in China and internationally. It operates through the Company, Science Company, Commerce Company, and Others segments. The company offers various product dosage forms, such as pills, powders, alcoholic preparations, capsules, oral liquids, and dripping pills. Its products are used … Read more

Beijing Tongrentang Co Ltd (600085) - Net Assets

Latest net assets as of September 2025: CN¥21.45 Billion CNY

Based on the latest financial reports, Beijing Tongrentang Co Ltd (600085) has net assets worth CN¥21.45 Billion CNY as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥31.82 Billion) and total liabilities (CN¥10.36 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥21.45 Billion
% of Total Assets 67.43%
Annual Growth Rate 17.24%
5-Year Change 34.44%
10-Year Change 92.27%
Growth Volatility 29.39

Beijing Tongrentang Co Ltd - Net Assets Trend (1994–2024)

This chart illustrates how Beijing Tongrentang Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Beijing Tongrentang Co Ltd (1994–2024)

The table below shows the annual net assets of Beijing Tongrentang Co Ltd from 1994 to 2024.

Year Net Assets Change
2024-12-31 CN¥20.90 Billion +3.18%
2023-12-31 CN¥20.26 Billion +9.77%
2022-12-31 CN¥18.45 Billion +10.69%
2021-12-31 CN¥16.67 Billion +7.24%
2020-12-31 CN¥15.55 Billion +6.04%
2019-12-31 CN¥14.66 Billion +0.90%
2018-12-31 CN¥14.53 Billion +10.34%
2017-12-31 CN¥13.17 Billion +9.02%
2016-12-31 CN¥12.08 Billion +11.11%
2015-12-31 CN¥10.87 Billion +25.72%
2014-12-31 CN¥8.65 Billion +10.32%
2013-12-31 CN¥7.84 Billion +39.84%
2012-12-31 CN¥5.60 Billion +16.49%
2011-12-31 CN¥4.81 Billion +13.97%
2010-12-31 CN¥4.22 Billion +7.88%
2009-12-31 CN¥3.91 Billion +6.39%
2008-12-31 CN¥3.68 Billion +8.81%
2007-12-31 CN¥3.38 Billion +14.46%
2006-12-31 CN¥2.95 Billion +3.12%
2005-12-31 CN¥2.86 Billion +10.30%
2004-12-31 CN¥2.60 Billion +29.87%
2003-12-31 CN¥2.00 Billion +21.01%
2002-12-31 CN¥1.65 Billion +13.57%
2001-12-31 CN¥1.45 Billion +29.06%
2000-12-31 CN¥1.13 Billion +48.57%
1999-12-31 CN¥758.76 Million +11.99%
1998-12-31 CN¥677.52 Million +10.20%
1997-12-31 CN¥614.83 Million +167.34%
1996-12-31 CN¥229.98 Million +15.89%
1995-12-31 CN¥198.44 Million +12.06%
1994-12-31 CN¥177.08 Million --

Equity Component Analysis

This analysis shows how different components contribute to Beijing Tongrentang Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 49263.3% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings CN¥8.39 Billion 63.55%
Common Stock CN¥1.37 Billion 10.39%
Other Comprehensive Income CN¥1.67 Billion 12.66%
Other Components CN¥1.77 Billion 13.40%
Total Equity CN¥13.20 Billion 100.00%

Beijing Tongrentang Co Ltd Competitors by Market Cap

The table below lists competitors of Beijing Tongrentang Co Ltd ranked by their market capitalization.

Company Market Cap
CI Financial Corp.
PINK:CIXXF
 		$2.66 Billion
GCL-Poly Energy Holdings Limited
PINK:GCPEF
 		$2.67 Billion
All Winner Technology Co Ltd
SHE:300458
 		$2.67 Billion
Krungthai Card Public Company Limited
PINK:KGTHY
 		$2.67 Billion
PGE Polska Grupa Energetyczna S.A
PINK:PPOEF
 		$2.66 Billion
Komercní banka a.s.
PINK:KMERF
 		$2.66 Billion
American Eagle Outfitters Inc
NYSE:AEO
 		$2.66 Billion
Vontobel Holding AG
PINK:VONHF
 		$2.66 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Beijing Tongrentang Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 13,058,012,147 to 13,196,323,218, a change of 138,311,071 (1.1%).
  • Net income of 1,526,274,931 contributed positively to equity growth.
  • Dividend payments of 1,373,070,278 reduced retained earnings.
  • Other comprehensive income increased equity by 1,559,738,451.
  • Other factors decreased equity by 1,574,632,033.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CN¥1.53 Billion +11.57%
Dividends Paid CN¥1.37 Billion -10.4%
Other Comprehensive Income CN¥1.56 Billion +11.82%
Other Changes CN¥-1.57 Billion -11.93%
Total Change CN¥- 1.06%

Book Value vs Market Value Analysis

This analysis compares Beijing Tongrentang Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 3.11x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 220.06x to 3.11x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1994-12-31 CN¥0.14 CN¥29.95 x
1995-12-31 CN¥0.15 CN¥29.95 x
1996-12-31 CN¥0.18 CN¥29.95 x
1997-12-31 CN¥0.47 CN¥29.95 x
1998-12-31 CN¥0.52 CN¥29.95 x
1999-12-31 CN¥0.58 CN¥29.95 x
2000-12-31 CN¥0.73 CN¥29.95 x
2001-12-31 CN¥0.96 CN¥29.95 x
2002-12-31 CN¥1.07 CN¥29.95 x
2003-12-31 CN¥1.26 CN¥29.95 x
2004-12-31 CN¥1.65 CN¥29.95 x
2005-12-31 CN¥1.81 CN¥29.95 x
2006-12-31 CN¥1.84 CN¥29.95 x
2007-12-31 CN¥2.04 CN¥29.95 x
2008-12-31 CN¥2.19 CN¥29.95 x
2009-12-31 CN¥2.33 CN¥29.95 x
2010-12-31 CN¥2.50 CN¥29.95 x
2011-12-31 CN¥2.67 CN¥29.95 x
2012-12-31 CN¥3.06 CN¥29.95 x
2013-12-31 CN¥3.73 CN¥29.95 x
2014-12-31 CN¥4.06 CN¥29.95 x
2015-12-31 CN¥5.20 CN¥29.95 x
2016-12-31 CN¥5.68 CN¥29.95 x
2017-12-31 CN¥6.14 CN¥29.95 x
2018-12-31 CN¥6.75 CN¥29.95 x
2019-12-31 CN¥6.74 CN¥29.95 x
2020-12-31 CN¥7.17 CN¥29.95 x
2021-12-31 CN¥7.75 CN¥29.95 x
2022-12-31 CN¥8.61 CN¥29.95 x
2023-12-31 CN¥9.52 CN¥29.95 x
2024-12-31 CN¥9.62 CN¥29.95 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Beijing Tongrentang Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 11.57%
  • The company shows good efficiency in utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 8.21%
  • • Asset Turnover: 0.60x
  • • Equity Multiplier: 2.36x
  • Recent ROE (11.57%) is below the historical average (14.97%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1994 35.99% 13.77% 0.73x 3.59x CN¥46.02 Million
1995 29.91% 11.85% 0.78x 3.23x CN¥39.51 Million
1996 38.89% 16.64% 0.82x 2.84x CN¥66.44 Million
1997 16.65% 16.32% 0.62x 1.64x CN¥40.88 Million
1998 18.11% 17.25% 0.65x 1.63x CN¥54.94 Million
1999 18.36% 16.67% 0.70x 1.57x CN¥63.40 Million
2000 15.38% 14.32% 0.61x 1.76x CN¥51.29 Million
2001 16.03% 12.38% 0.75x 1.73x CN¥75.04 Million
2002 17.92% 12.55% 0.81x 1.76x CN¥110.45 Million
2003 14.64% 11.04% 0.79x 1.68x CN¥75.96 Million
2004 13.39% 11.73% 0.69x 1.66x CN¥72.66 Million
2005 12.82% 11.56% 0.69x 1.61x CN¥66.28 Million
2006 6.51% 6.51% 0.63x 1.59x CN¥-83.76 Million
2007 8.75% 8.62% 0.64x 1.58x CN¥-33.18 Million
2008 9.07% 8.81% 0.65x 1.59x CN¥-26.53 Million
2009 9.41% 8.79% 0.66x 1.62x CN¥-18.02 Million
2010 10.54% 8.97% 0.70x 1.69x CN¥17.53 Million
2011 12.60% 7.17% 0.83x 2.11x CN¥90.38 Million
2012 14.33% 7.58% 0.78x 2.43x CN¥172.18 Million
2013 13.07% 7.53% 0.73x 2.37x CN¥154.22 Million
2014 13.84% 7.88% 0.75x 2.35x CN¥211.77 Million
2015 12.30% 8.03% 0.76x 2.01x CN¥163.64 Million
2016 11.97% 7.72% 0.71x 2.19x CN¥153.82 Million
2017 12.09% 7.61% 0.71x 2.22x CN¥175.77 Million
2018 12.25% 7.98% 0.69x 2.21x CN¥208.19 Million
2019 10.67% 7.42% 0.63x 2.27x CN¥61.93 Million
2020 10.49% 8.04% 0.59x 2.22x CN¥48.28 Million
2021 11.54% 8.40% 0.58x 2.36x CN¥163.98 Million
2022 12.09% 9.29% 0.57x 2.29x CN¥246.61 Million
2023 12.78% 9.34% 0.59x 2.30x CN¥363.03 Million
2024 11.57% 8.21% 0.60x 2.36x CN¥206.64 Million

Industry Comparison

This section compares Beijing Tongrentang Co Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $5,061,893,866
  • Average return on equity (ROE) among peers: 4.12%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Beijing Tongrentang Co Ltd (600085) CN¥21.45 Billion 35.99% 0.48x $2.66 Billion
Shenzhen Neptunus Bioengineering Co Ltd (000078) $2.84 Billion -41.97% 9.13x $608.50 Million
Anhui Fengyuan Pharmaceutical Co Ltd (000153) $1.29 Billion 4.72% 1.33x $324.94 Million
Shan Dong Dong-E E-Jiao Co Ltd (000423) $11.33 Billion 18.40% 0.22x $3.03 Billion
Wedge Industrial Co Ltd (000534) $1.30 Billion 13.53% 1.39x $1.92 Billion
Yunnan Baiyao Group Co Ltd (000538) $525.21 Million 17.84% 0.75x $5.59 Billion
Hainan Haiyao Co Ltd (000566) $4.63 Billion -3.44% 1.33x $704.71 Million
Tus Pharmaceutical Group Co Ltd (000590) $268.78 Million 10.37% 0.50x $325.99 Million
Northeast Pharmaceutical Group Co Ltd (000597) $2.07 Billion 2.59% 1.71x $425.60 Million
Jilin Aodong Pharmaceutical Group Co Ltd (000623) $22.44 Billion 6.25% 0.15x $2.04 Billion
Renhe Pharmacy Co Ltd (000650) $3.91 Billion 12.94% 0.18x $777.45 Million